Parkinson’s disease (No. = 48) | Vascular parkinsonism (No. = 27) | Control (No. = 29) | Chi-square test | ||
---|---|---|---|---|---|
Frequency (%) | Frequency (%) | Frequency (%) | P value | ||
Age (Mean /SD) ^ | 58.6 (6.2) | 63.1 (10.3) | 58.86 (8.2) | 0.054 | |
Gender(Male/female) | 36 / 12 (75% / 25%) | 21 / 6 (77.8%/ 22.2%) | 16 / 13 (55.2%/ 44.8%) | 0.111 | |
Functioning | Non-functioning | 5 (10.4%) | 5 (18.5%) | 0 (0.0%) | 0.027* |
Functioning | 29 (60.4%) | 8 (29.6%) | 16 (55.2%) | ||
Retired | 14 (29.2%) | 14 (51.9%) | 13 (44.8%) | ||
Number of vascular risk factors | 0 | 26 (54.2%) | 0 (0.0%) | 29 (100%) | < 0.001* |
1 | 14 (29.2%) | 1 (3.7%) | 0 (0.0%) | ||
2 | 6 (12.5%) | 15 (55.6%) | 0 (0.0%) | ||
3 | 2 (4.2%) | 8 (29.6%) | 0 (0.0%) | ||
4 | 0 (0.0%) | 3 (11.1%) | 0 (0.0%) | ||
Smoking | Non-smoker | 32 (66.7%) | 11 (40.7%) | 25 (86.2%) | < 0.001* |
Smoker | 6 (12.5%) | 16 (59.3%) | 4 (13.8%) | ||
Ex-smoker | 10 (20.8%) | 0 (0.0%) | 0 (0.0%) | ||
Years of educationτ(median/range) | 6 (0–18) | 8 (0–13) | 7 (0–16) | 0.613 | |
Substance abuse | 2 (4.2%) | 0 (0.0%) | 0 (0.0%) | 0.304 | |
Diabetes mellitus | 9 (18.8%) | 7 (25.9%) | 0 (0.0%) | 0.018* | |
Hypertension | 13 (27.1%) | 25 (92.6%) | 0 (0.0%) | < 0.001* | |
Hepatitis C virus | 1 (2.1%) | 0 (0.0%) | 0 (0.0%) | 0.555 | |
Ischemic heart disease | 8 (16.7%) | 9 (33.3%) | 0 (0.0%) | 0.003* | |
Hyperlipidemia | 2 (4.2%) | 27 (100.0%) | 0 (0.0%) | < 0.001* | |
Consanguinity | 14 (29.2%) | 1 (3.7%) | 0 (0.0%) | < 0.001* | |
Family History of Neuropsychiatric Illness | No | 35 (72.9%) | 26 (96.3%) | 29 (100.0%) | 0.025* |
Parkinson’s disease | 12 (25%) | 1 (3.7%) | 0 (0.0%) | ||
Psychiatric | 1 (2.1%) | 0 (0.0%) | 0 (0.0%) | ||
Dementia | 1 (2.1%) | 0 (0.0%) | 0 (0.0%) |